Eli Lilly Raises Financial Outlook After Strong Mounjaro International Sales, Focus Shifts to Foundayo Launch

Eli Lilly and Company reported strong financial results, driven by international sales of Mounjaro, and subsequently raised its financial outlook for the year. The company is now focusing on the upcoming launch of Foundayo.

The pharmaceutical company’s first quarter performance was bolstered by significant international demand for Mounjaro. As a result of this strong showing, Lilly increased its projected profit and revenue for the remainder of the year. Looking ahead, the company is shifting its attention to the market introduction of Foundayo.
n

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 30, 2026

Author

GOAI